Market Place
Sourcing Support
Experts Question Fda`s Leucovorin Approval Standard
12 Jan 2026 //
RAPS
Pfizer, GSK, Shionogi Sponsor London Run Of AMR Musical
04 Dec 2025 //
FIERCE PHARMA
GSK Presents Tv Special on Senior Athletes for Rsv Awareness
25 Jul 2025 //
FIERCE PHARMA
89% of HIV Patients Choose ViiV’s Long-Acting Injection
14 Jul 2025 //
BUSINESSWIRE
Gsk and Lifetime Launch Movie on Meningitis Impact
09 May 2025 //
BUSINESSWIRE
Energize Supports Global Healthcare Firms with Multi-buyer PPA
06 Feb 2025 //
BUSINESSWIRE
12.7M Invested In NTDs, Malaria Diagnostics, Drug Development
29 Jan 2025 //
PR NEWSWIRE
GSK and Oxford University ink cancer vaccine research pact
26 Jan 2025 //
FIERCE BIOTECH
Employees` LinkedIn likes land AstraZeneca and GSK in hot water
06 Dec 2024 //
FIERCE PHARMA
ViiV Health Expand Data on Long-Acting HIV Therapies at HIV Glasgow
07 Nov 2024 //
BUSINESSWIRE
GSK and Boston scientists team up to tackle lung diseases
19 Oct 2024 //
PRESS RELEASE
IntegriChain Presents Awards At The Access Insights Conference
16 Oct 2024 //
PR NEWSWIRE
GSK makes Brooke Shields the star of shingles vaccination push
17 Sep 2024 //
FIERCE PHARMA
Brooke Shields Promotes GSK`s Shingles Awareness Campaign
16 Sep 2024 //
PR NEWSWIRE
Beta blocker treatment paradigm shifts for myocardial infarction
03 Sep 2024 //
PHARMACEUTICAL TECHNOLOGY
GSK signs AI pact with Ochre to pinpoint source of liver disease
12 Jun 2024 //
FIERCE BIOTECH
ViiV Healthcare Announces Data at CROI Indicating Efficacy of Cabenuva
06 Mar 2024 //
BUSINESSWIRE
ViiV Healthcare receives approval from China’s NMPA for Vocabria
27 Oct 2023 //
PRESS RELEASE
ViiV Healthcare to present 23 abstracts from innovative HIV treatment
18 Oct 2023 //
BUSINESSWIRE
GSK and ViiV Healthcare to present scientific advancements at IDWeek 2023
10 Oct 2023 //
PRESS RELEASE
GSK to sell 2.9% stake in former consumer healthcare business Haleon
05 Oct 2023 //
REUTERS
GSK`s ViiV Healthcare takes Shutterstock-partnered campaign in new direction
21 Sep 2023 //
ENDPTS
Quadria to invest up to Rs 1,300 cr in GSK Velu`s Maxivision Eye Hospital
12 Jul 2023 //
ECONOMIC TIMES
GSK`s ViiV, Pfizer and Roche score high with patient groups
27 Apr 2022 //
FIERCEPHARMA
Factbox: Front runners in development of antibody drugs against COVID-19
17 Nov 2021 //
REUTERS
GSK brings Johns Hopkins prof and Blade co-founder on board; & more
27 Oct 2021 //
ENDPTS
GSK vaccine R&D chief heads for microbiome startup Viome
15 Apr 2021 //
FIERCEBIOTECH
FierceMadness winner Dovato shows full picture of HIV patients
09 Apr 2021 //
FIERCEPHARMA
NLS Obtains License to Full Regulatory Data Package and Proprietary
12 Mar 2021 //
PRNEWSWIRE
Biotech partner drops GSK’s adjuvant as it moves Covid-19 vaccine into PhII/III
01 Feb 2021 //
ENDPTS
Covid-19 claims another PDUFA victim as GlaxoSmithKline pushes back planned
20 Jan 2021 //
ENDPTS
COVID-19 S-Trimer vaccine candidates show promise in early trials
07 Dec 2020 //
EUROPEANPHARMACEUTICALREVIEW
A coronavirus vaccine may arrive next year. `Herd immunity` will take longer.
04 May 2020 //
BIOPHARMADIVE
Covid-19 vaccine tracker updated to include GSK/Sanofi collaboration
16 Apr 2020 //
ENDPTS
Kenya becomes third African nation to introduce malaria vaccine
13 Sep 2019 //
REUTERS
Vaccination against cervical cancer virus impacts stopping infections.
27 Jun 2019 //
REUTERS
GSK announces positive data from DREAMM-1 study of anti-BCMA ADC
23 Mar 2019 //
PHARMABIZ
An audience with Hal Barron
11 Feb 2019 //
NATURE
Sanofi’s R&D remodeling spotlights what’s hot in oncology today
09 Feb 2019 //
ENDPTS
How a decades-old HIV drug might help treat Alzheimer`s, age-related diseases
08 Feb 2019 //
FIERCE BIOTECH
Hal Barron’s GSK team continues to cull resp drugs in big shift to oncology R&D
06 Feb 2019 //
ENDPTS
GSK looks to oncology for growth as Advair generic hits
06 Feb 2019 //
FIERCE PHARMA
Five reasons biologics contract manufacturing will hit $87.6bn by 2027
28 Jan 2019 //
BIOPHARMA-REPORTER
A biotech`s M&A invitation and Editas` next CRISPR step
12 Jan 2019 //
BIOPHARMA DIVE
GSK upbeat on its return to oncology market
11 Jan 2019 //
PMLIVE
5 Biopharma Trends to Watch in 2019
01 Jan 2019 //
GEN
First-line ovarian approval cements AZ’s Lynparza lead
20 Dec 2018 //
PM LIVE
Clovis should put itself up for sale, activist Armistice says: report
19 Dec 2018 //
FIERCE PHARMA
A new analysis spotlights the top 20 drugs in the late-stage pipeline
14 Dec 2018 //
ENDPTS
GlaxoSmithKline`s Shingrix shortage expected to persist `throughout 2019`
12 Dec 2018 //
FIERCE PHARMA
Sue Dillon, Karyn O’Neil steer fledgling Aro Biotherapeutics to $13M debut
11 Dec 2018 //
ENDPTS
Will Clovis be the next PARP maker to get swallowed up?
08 Dec 2018 //
FIERCE PHARMA
Gardasil-Cervarix divide, flu vaccines and more
07 Dec 2018 //
FIERCE PHARMA
GlaxoSmithKline weighs men B shot Bexsero`s promise against gonorrhea
27 Nov 2018 //
FIERCE PHARMA
A Superbug Needs to Be Stopped. A Glaxo Vaccine May Slow It Down
16 Nov 2018 //
BLOOMBERG
Gene study reveals secrets of parasitic worms, possible treatments
05 Nov 2018 //
REUTERS
SCS, physical therapy combo sees paralyzed walk again; caveats remain
04 Nov 2018 //
FIERCE BIOTECH
Stanford spinout Forty Seven burnishes its prospects from an impressive PhIb
01 Nov 2018 //
ENDPTS
Long-lasting HIV injection is a step closer after second GSK study
31 Oct 2018 //
REUTERS
